Work by device manufacturers to improve the performance of pulse oximeters on people with darker skin has progressed little since the Food and Drug Administration asked manufacturers in 2013 to voluntarily test the devices on more diverse skin tones, according to a study published Monday in JAMA. The study and a related editorial suggest clearer guidance, enforcement, and possibly legal action may be necessary to ensure the devices work well on all skin tones.
The new research analyzed paperwork submitted for FDA approval to market a device for 767 oximeters that had been approved between 1978-2024 and had accessible information about performance testing. The authors found references to skin tone, pigmentation, or race in 4% of the documents submitted before the FDA made its suggestion to diversify skin tone testing in 2013. That number rose to only 25% of submissions after the guidance was released — a number the authors said was still far too low and shows how little has been done to fix a problem — poorer performance on darker skinned patients — known for decades.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.